Heart regeneration using pluripotent stem cells.

Journal of cardiology
Shin KadotaYuji Shiba

Abstract

Pluripotent stem cells (PSCs), which include embryonic and induced pluripotent stem cells (ESCs and iPSCs, respectively), have great potential in regenerative medicine for heart diseases due to their virtually unlimited cardiogenic capacity. Many preclinical studies have described the functional benefits after transplantation of PSC-derived cardiomyocytes (PSC-CMs). However, transient ventricular arrhythmias were detected after injection into non-human primates and swine ischemic hearts; as engrafted PSC-CMs form an electrical coupling between host and graft, the immature characteristics of PSC-CMs may serve as an ectopic pacemaker. We are entering a critical time in the development of novel therapies using PSC-CMs, with the recent first clinical trial using human iPSC-CMs (hiPSC-CMs) being launched in Japan. In this review, we summarize the updated knowledge, perspectives, and limitations of PSC-CMs for heart regeneration.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
May 10, 2001·Journal of Molecular and Cellular Cardiology·M ZhangC E Murry
Sep 28, 2004·Nature Biotechnology·Izhak KehatLior Gepstein
Apr 4, 2009·Science·Olaf BergmannJonas Frisén
Mar 26, 2010·Nature·Chris JoplingJuan Carlos Izpisúa Belmonte
Feb 26, 2011·Science·Enzo R PorrelloHesham A Sadek
May 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xiaojun LianSean P Palecek
Feb 13, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Tsukasa KamakuraTakeshi Kimura
Mar 7, 2013·Stem Cells and Development·Scott D LundyMichael A Laflamme
Apr 19, 2013·Nature·Ahmed I MahmoudHesham A Sadek
Nov 21, 2013·Development·Todd HeallenJames F Martin
Feb 12, 2014·Journal of Cardiovascular Pharmacology and Therapeutics·Yuji ShibaMichael A Laflamme
Jun 16, 2014·Nature Methods·Paul W BurridgeJoseph C Wu
Jun 23, 2015·Nature·Wataru KimuraHesham A Sadek
Aug 14, 2015·Nature Protocols·Henning KempfRobert Zweigerdt
Dec 15, 2015·Circulation Research·Bernhard J HaubnerJosef M Penninger
Apr 7, 2016·Cell Metabolism·Shugo TohyamaKeiichi Fukuda
Nov 1, 2016·Nature·Yuji NakadaHesham A Sadek
Dec 13, 2016·Nature Biotechnology·Stephanie I ProtzeGordon M Keller
Mar 16, 2017·The New England Journal of Medicine·Michiko MandaiMasayo Takahashi
Apr 30, 2017·Circulation Research·Florian WeinbergerThomas Eschenhagen
May 16, 2017·Nature Biotechnology·Germán G GornalusseDavid W Russell
Feb 2, 2018·Journal of the American College of Cardiology·Philippe MenaschéJérôme Larghero
Apr 6, 2018·Nature·Kacey Ronaldson-BouchardGordana Vunjak-Novakovic
Jun 16, 2018·Current Cardiology Reports·John P Leach, James F Martin

❮ Previous
Next ❯

Citations

Mar 7, 2021·Nanomaterials·Laura SaludasMaría J Blanco-Prieto
Aug 20, 2021·Frontiers in Bioengineering and Biotechnology·Nataliia Naumova, Laura Iop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.